GlassScriptPhysician profile
Atul Kukar
NPI 1225054984
$15,368.19
in general payments reported to CMS, 2019-2025
40 companies · $2,424 in 2025
The $2,424 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $1,990 · 2020: $210 · 2021: $2,316 · 2022: $3,064 · 2023: $3,125 · 2024: $2,240 · 2025: $2,424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,788.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,738.81 | 2019-2025 | Pressurewire, Xience Skypoint, Cardiomems |
| Shockwave Medical, INC | $1,966.89 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Terumo Medical Corporation | $1,348.50 | 2019-2025 | Metacross Otw, Glidewire, Glidesheath Slender |
| Boston Scientific Corporation | $975.96 | 2019-2025 | General - Therapies, General - Balloon Catheters, Synergy |
| Cvrx, INC. | $777.75 | 2022-2023 | Barostim Neo System |
| Medtronic, INC. | $770.02 | 2021-2025 | Venaseal |
| Cardiovascular Systems INC. | $650.80 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $629.23 | 2019-2025 | |
| Amgen INC. | $552.18 | 2019-2023 | Repatha |
| Stryker Corporation | $429.63 | 2025 | Artix Mt, Flowtriever |
| Bard Peripheral Vascular, INC. | $416.68 | 2019 | |
| Philips North America LLC | $411.66 | 2021-2025 | Mcot, (Ck4) Mcot |
| Cagent Vascular INC | $382.52 | 2022-2023 | Serrantor |
| Endologix LLC | $358.04 | 2024 | Torus Stent Graft System, Endocross Device |
| Janssen Pharmaceuticals, INC | $354.76 | 2020-2024 | Xarelto |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $317.33 | 2021-2025 | Onpattro, Amvuttra |
| Janssen Scientific Affairs, LLC | $278.44 | 2021-2023 | Xarelto |
| Inari Medical, INC. | $240.11 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Spectrawave, INC | $238.17 | 2024 | Hypervue Imaging System, Starlight Imaging Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $231.59 | 2022-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $175.36 | 2019-2024 | Farxiga |
| Opsens INC. | $173.97 | 2022 | |
| Abiomed | $161.02 | 2023 | Impella |
| Esperion Therapeutics, INC. | $149.15 | 2021 | |
| Intra-Sana Laboratories | $100.11 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Scpharmaceuticals INC. | $88.94 | 2025 | |
| Teleflex LLC | $68.56 | 2023 | Manta |
| Kiniksa Pharmaceuticals International, Plc | $67.45 | 2024 | Arcalyst |
| Tactile Systems Technology INC | $64.73 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Ge Healthcare | $49.68 | 2024 | |
| Irhythm Technologies, INC. | $28.37 | 2024 | Zio Xt Patch, Zio Monitor |
| Cordis US Corp. | $26.37 | 2023 | Radial 360 |
| Cook Medical LLC | $25.00 | 2019 | |
| Renalytix Ai, INC. | $24.67 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Preventice Services, LLC | $21.82 | 2020 | |
| Ionis Pharmaceuticals, INC. | $21.72 | 2025 | Tryngolza |
| Amarin Pharma, INC. | $18.92 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.58 | 2025 | |
| Chiesi USA, INC. | $15.70 | 2023 | Kengreal |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$750.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Atul Kukar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.